Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
77
Frequently Asked Questions
What is Market Cap of ArriVent BioPharma Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. ArriVent BioPharma Inc. market cap is $1.43B.
What is the 52-week high for ArriVent BioPharma Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ArriVent BioPharma Inc. 52 week high is $35.83 as of August 07, 2026.
What is the 52-week low for ArriVent BioPharma Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ArriVent BioPharma Inc. 52 week low is $16.10 as of August 07, 2026.
What is ArriVent BioPharma Inc. stock price today?
ArriVent BioPharma Inc. stock price today is $31.01.
What was ArriVent BioPharma Inc. stock price yesterday?
ArriVent BioPharma Inc. stock price yesterday was $30.61.
What is the PE ratio of ArriVent BioPharma Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. ArriVent BioPharma Inc.'s P/E ratio is -8.78.
What is the Price-to-Book ratio of ArriVent BioPharma Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. ArriVent BioPharma Inc. P/B ratio is 4.3368.
What is the 50-day moving average of ArriVent BioPharma Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. ArriVent BioPharma Inc. 50-day moving average is $31.54.
How many employees does ArriVent BioPharma Inc. have?
